FIELD: pharmaceuticals.
SUBSTANCE: invention relates to an inhibitor that is a pyridazine derivative, namely a compound of formula (V), its stereoisomer or a pharmaceutically acceptable salt thereof, where R9 is C3-6 cycloalkyl, R is C1-6 alkoxy, R3 is selected from a group consisting of hydrogen and halogen, R4 is cyclopropyl, R5 and R6 are hydrogen, x is either 0 or 1. The invention also relates to a method of producing a compound of formula (V), to a pharmaceutical composition containing it and to its use for the production of a TYK2 inhibitory medicinal product for the treatment of an inflammatory disease and an autoimmune disease, wherein the inflammatory disease and the autoimmune disease are selected from the group consisting of rheumatoid arthritis, dermatitis, psoriasis and inflammatory bowel disease.
EFFECT: development of a safer selective TYK2 inhibitor for the treatment of inflammatory and autoimmune diseases.
10 cl, 1 dwg, 121 ex, 5 tbl
Authors
Dates
2023-11-17—Published
2020-01-20—Filed